{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:59:28Z","timestamp":1783576768401,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008590","name":"Dr. Ralph and Marian Falk Medical Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06208-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:17:24Z","timestamp":1776406644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-9865","authenticated-orcid":false,"given":"Amar","family":"Yeware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callum","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-1999","authenticated-orcid":false,"given":"Andrea","family":"Pennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-1996","authenticated-orcid":false,"given":"Jacques","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"6208_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lungcan.2016.06.016","volume":"99","author":"K Shien","year":"2016","unstructured":"Shien K, Papadimitrakopoulou VA, Wistuba II (2016) Predictive biomarkers of response to PD-1\/PD-L1 immune checkpoint inhibitors in non\u2013small cell lung cancer. Lung Cancer 99:79\u201387","journal-title":"Lung Cancer"},{"issue":"3","key":"6208_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.32604\/or.2023.028227","volume":"31","author":"LU Liu","year":"2023","unstructured":"Liu LU et al (2023) High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation. Oncol Res 31(3):275\u2013286","journal-title":"Oncol Res"},{"key":"6208_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2019.03.012","volume":"131","author":"KM Kerr","year":"2019","unstructured":"Kerr KM et al (2019) A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. Lung Cancer 131:95\u2013103","journal-title":"Lung Cancer"},{"issue":"49","key":"6208_CR4","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.1073\/pnas.0406351101","volume":"101","author":"RH Thompson","year":"2004","unstructured":"Thompson RH et al (2004) Costimulatory B7\u2013H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A 101(49):17174\u201317179","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"6208_CR5","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1158\/1078-0432.CCR-16-1821","volume":"23","author":"JC Sunshine","year":"2017","unstructured":"Sunshine JC et al (2017) PD-L1 Expression in melanoma: a quantitative immunohistochemical antibody comparison. Clin Cancer Res 23(16):4938\u20134944","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6208_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/nov172","volume":"18","author":"EK Nduom","year":"2016","unstructured":"Nduom EK et al (2016) PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol 18(2):195\u2013205","journal-title":"Neuro Oncol"},{"issue":"18","key":"6208_CR7","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1158\/1078-0432.CCR-19-1131","volume":"25","author":"A Matikas","year":"2019","unstructured":"Matikas A et al (2019) Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data. Clin Cancer Res 25(18):5717\u20135726","journal-title":"Clin Cancer Res"},{"issue":"8","key":"6208_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H et al (2002) Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793\u2013800","journal-title":"Nat Med"},{"issue":"1","key":"6208_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","volume":"6","author":"G Jun","year":"2018","unstructured":"Jun G et al (2018) Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer 6(1):8","journal-title":"J Immunother Cancer"},{"issue":"2","key":"6208_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4049\/jimmunol.1101412","volume":"188","author":"R Gary","year":"2012","unstructured":"Gary R et al (2012) Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis. J Immunol 188(2):744\u2013752","journal-title":"J Immunol"},{"issue":"9","key":"6208_CR11","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41375-020-0737-9","volume":"34","author":"M Kawashima","year":"2020","unstructured":"Kawashima M et al (2020) PD-L1\/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma. Leukemia 34(9):2405\u20132417","journal-title":"Leukemia"},{"issue":"1","key":"6208_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"6208_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12951-023-01969-1","volume":"21","author":"L Yu","year":"2023","unstructured":"Yu L et al (2023) Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials. J Nanobiotechnology 21(1):218","journal-title":"J Nanobiotechnology"},{"issue":"7718","key":"6208_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G et al (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718):382\u2013386","journal-title":"Nature"},{"key":"6208_CR15","doi-asserted-by":"publisher","first-page":"1097117","DOI":"10.3389\/fimmu.2022.1097117","volume":"13","author":"S Akbar","year":"2022","unstructured":"Akbar S et al (2022) Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1\/PD-L1 therapy in non-small cell lung cancer patients. Front Immunol 13:1097117","journal-title":"Front Immunol"},{"issue":"2","key":"6208_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio M et al (2019) Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell 177(2):414-427.e13","journal-title":"Cell"},{"issue":"3","key":"6208_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aar2766","volume":"4","author":"FL Ricklefs","year":"2018","unstructured":"Ricklefs FL et al (2018) Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv 4(3):eaar2766","journal-title":"Sci Adv"},{"issue":"12","key":"6208_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470\u20131476","journal-title":"Nat Cell Biol"},{"key":"6208_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ceb.2014.05.004","volume":"29","author":"J Kowal","year":"2014","unstructured":"Kowal J, Tkach M, Th\u00e9ry C (2014) Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29:116\u2013125","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"6208_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","volume":"8","author":"C Tricarico","year":"2017","unstructured":"Tricarico C, Clancy J, D\u2019Souza-Schorey C (2017) Biology and biogenesis of shed microvesicles. Small GTPases 8(4):220\u2013232","journal-title":"Small GTPases"},{"issue":"1","key":"6208_CR21","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24641","volume":"3","author":"LA Mulcahy","year":"2014","unstructured":"Mulcahy LA, Pink RC, Carter DRF (2014) Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3(1):24641","journal-title":"J Extracell Vesicles"},{"issue":"35","key":"6208_CR22","doi-asserted-by":"publisher","first-page":"30911","DOI":"10.1074\/jbc.M111.271155","volume":"286","author":"M Valapala","year":"2011","unstructured":"Valapala M, Vishwanatha JK (2011) Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J Biol Chem 286(35):30911\u201330925","journal-title":"J Biol Chem"},{"issue":"1","key":"6208_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41536-022-00244-5","volume":"7","author":"R Das","year":"2022","unstructured":"Das R et al (2022) A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation. NPJ Regen Med 7(1):41","journal-title":"NPJ Regen Med"},{"issue":"9","key":"6208_CR24","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1182\/bloodadvances.2020001711","volume":"4","author":"J Giri","year":"2020","unstructured":"Giri J, Galipeau J (2020) Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv 4(9):1987\u20131997","journal-title":"Blood Adv"},{"issue":"1","key":"6208_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12632","volume":"7","author":"C-W Li","year":"2016","unstructured":"Li C-W et al (2016) Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 7(1):12632","journal-title":"Nat Commun"},{"issue":"17","key":"6208_CR26","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1523\/JNEUROSCI.21-17-06467.2001","volume":"21","author":"R Heidelberger","year":"2001","unstructured":"Heidelberger R (2001) ATP is required at an early step in compensatory endocytosis in synaptic terminals. J Neurosci 21(17):6467\u20136474","journal-title":"J Neurosci"},{"issue":"3","key":"6208_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/0265673031000065042","volume":"19","author":"JR Lepock","year":"2003","unstructured":"Lepock JR (2003) Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia 19(3):252\u2013266","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"6208_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1083\/jcb.122.6.1267","volume":"122","author":"J Lepock","year":"1993","unstructured":"Lepock J, Frey H, Ritchie K (1993) Protein denaturation in intact hepatocytes and isolated cellular organelles during heat shock. J Cell Biol 122(6):1267\u20131276","journal-title":"J Cell Biol"},{"issue":"4","key":"6208_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","volume":"21","author":"B Diskin","year":"2020","unstructured":"Diskin B et al (2020) PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer. Nat Immunol 21(4):442\u2013454","journal-title":"Nat Immunol"},{"issue":"1","key":"6208_CR30","doi-asserted-by":"publisher","first-page":"1995166","DOI":"10.1080\/2162402X.2021.1995166","volume":"10","author":"JW Li","year":"2021","unstructured":"Li JW et al (2021) Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma. Oncoimmunology 10(1):1995166","journal-title":"Oncoimmunology"},{"issue":"1","key":"6208_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41416-023-02491-9","volume":"130","author":"Z Eslami-S","year":"2024","unstructured":"Eslami-S Z et al (2024) Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer. Br J Cancer 130(1):63\u201372","journal-title":"Br J Cancer"},{"issue":"1","key":"6208_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13046-022-02379-1","volume":"41","author":"D de Miguel-Perez","year":"2022","unstructured":"de Miguel-Perez D et al (2022) Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with\u00a0non-small cell lung cancer. J Exp Clin Cancer Res 41(1):186","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6208_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-024-01364-2","volume":"57","author":"J Kim","year":"2025","unstructured":"Kim J et al (2025) Trogocytosis-mediated immune evasion in the tumor microenvironment. Exp Mol Med 57(1):1\u201312","journal-title":"Exp Mol Med"},{"issue":"9","key":"6208_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ni0903-815","volume":"4","author":"E Joly","year":"2003","unstructured":"Joly E, Hudrisier D (2003) What is trogocytosis and what is its purpose? Nat Immunol 4(9):815\u2013815","journal-title":"Nat Immunol"},{"issue":"11","key":"6208_CR35","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.1697","volume":"7","author":"M Riihim\u00e4ki","year":"2018","unstructured":"Riihim\u00e4ki M et al (2018) Clinical landscape of cancer metastases. Cancer Med 7(11):5534\u20135542","journal-title":"Cancer Med"},{"issue":"5","key":"6208_CR36","first-page":"1477","volume":"10","author":"S Wang","year":"2020","unstructured":"Wang S et al (2020) Incidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study. Am J Cancer Res 10(5):1477\u20131517","journal-title":"Am J Cancer Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06208-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:25:31Z","timestamp":1779935131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06208-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6208"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06208-y","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial or non-financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"229"}}